| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2850387 | American Heart Journal | 2011 | 12 Pages |
Abstract
The current totality of evidence provides only modest support for a benefit of aspirin in patients without clinical cardiovascular disease, which is offset by its risk. For every 1,000 subjects treated with aspirin over a 5-year period, aspirin would prevent 2.9 MCE and cause 2.8 major bleeds.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jeffrey S. MD, MS, FACC, Anuradha MD, Mori J. MD, Gizelle S. PhD, William R. MD,